Abbott Laboratories logo is displayed on a screen at the NYSE in New York (Reuters) - The U.S. Food and Drug Administration on Thursday alerted healthcare providers about a potential clip lock issue ...
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage. "These events appear ...
The FDA and Abbott are alerting healthcare providers about potential clip lock malfunctions with MitraClip Clip Delivery Systems, a heart valve repair device manufactured by Abbott. Abbott issued an ...
Abbott said it had received an increased rate of reports of the devices failing to "establish final arm angle" or "clip opening while locked". (File) The U.S. Food and Drug Administration (USFDA) on ...
The U.S. Food and Drug Administration on Thursday alerted healthcare providers about a potential clip lock issue with Abbott Laboratories' MitraClip device used to stop heart valve leakage. Sept 8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results